A Connectome-wide Functional Signature of Transdiagnostic Risk for Mental Illness

Biological Psychiatry
Maxwell L ElliottAhmad R Hariri

Abstract

High rates of comorbidity, shared risk, and overlapping therapeutic mechanisms have led psychopathology research toward transdiagnostic dimensional investigations of clustered symptoms. One influential framework accounts for these transdiagnostic phenomena through a single general factor, sometimes referred to as the p factor, associated with risk for all common forms of mental illness. We build on previous research identifying unique structural neural correlates of the p factor by conducting a data-driven analysis of connectome-wide intrinsic functional connectivity (n = 605). We demonstrate that higher p factor scores and associated risk for common mental illness maps onto hyperconnectivity between visual association cortex and both frontoparietal and default mode networks. These results provide initial evidence that the transdiagnostic risk for common forms of mental illness is associated with patterns of inefficient connectome-wide intrinsic connectivity between visual association cortex and networks supporting executive control and self-referential processes, networks that are often impaired across categorical disorders.

References

Jun 1, 1996·Computers and Biomedical Research, an International Journal·R W Cox
Jul 2, 1998·Brain : a Journal of Neurology·M M Mesulam
Mar 7, 2001·The British Journal of Psychiatry : the Journal of Mental Science·M P AustinG M Goodwin
Apr 24, 2001·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·D PurvesZ Yang
Feb 12, 2008·Trends in Cognitive Sciences·Nico U F DosenbachSteven E Petersen
Mar 6, 2008·Nature Reviews. Neuroscience·Masao Ito
Apr 11, 2008·Annals of the New York Academy of Sciences·Randy L BucknerDaniel L Schacter
Jul 9, 2008·Current Opinion in Neurology·Michael Greicius
Oct 1, 2008·Neuroscience and Biobehavioral Reviews·Samantha J BroydEdmund J S Sonuga-Barke
Feb 18, 2009·Cerebral Cortex·Zarrar ShehzadMichael P Milham
Jul 4, 2009·NeuroImage·Douglas N Greve, Bruce Fischl
Feb 6, 2010·Proceedings of the National Academy of Sciences of the United States of America·D C GlahnJ Blangero
May 31, 2011·Nature Neuroscience·James Z Chadick, Adam Gazzaley
Jun 10, 2011·Journal of Neurophysiology·B T Thomas YeoRandy L Buckner
Jul 29, 2011·Journal of Neurophysiology·Randy L BucknerB T Thomas Yeo
Dec 16, 2011·Trends in Cognitive Sciences·Deanna M Barch, Alan Ceaser
Jan 10, 2012·Annual Review of Clinical Psychology·Susan Whitfield-Gabrieli, Judith M Ford
Mar 1, 2012·NeuroImage·Christian F Beckmann
Jun 2, 2012·World Psychiatry : Official Journal of the World Psychiatric Association (WPA)·Philip D Harvey, Martin Strassnig
Jun 26, 2012·Neuron·Joshua W Buckholtz, Andreas Meyer-Lindenberg
Aug 1, 2012·Journal of Abnormal Psychology·Benjamin B LaheyPaul J Rathouz
Oct 2, 2012·Annual Review of Psychology·Adele Diamond
Oct 13, 2012·Frontiers in Genetics·Matthew A Zapala, Nicholas J Schork
Nov 6, 2012·Human Brain Mapping·Keren-Happuch EJohn E Desmond
Nov 13, 2012·Trends in Cognitive Sciences·Alan AnticevicJohn H Krystal
Apr 11, 2013·Nature Reviews. Neuroscience·Katherine S ButtonMarcus R Munafò
Jul 5, 2013·Cerebral Cortex·Alan AnticevicDavid C Glahn
Jul 31, 2013·Nature Neuroscience·Michael W ColeTodd S Braver
Aug 13, 2013·Nature Genetics·UNKNOWN Cross-Disorder Group of the Psychiatric Genomics ConsortiumUNKNOWN International Inflammatory Bowel Disease Genetics Consortium (IIBDGC)
Sep 3, 2013·NeuroImage·Jonathan D PowerSteven E Petersen
Oct 17, 2013·Trends in Cognitive Sciences·Theodore P Zanto, Adam Gazzaley
Jul 30, 2014·Frontiers in Neuroscience·Bertrand ThirionJean-Baptiste Poline
Nov 2, 2014·Clinical Psychological Science : a Journal of the Association for Psychological Science·Avshalom CaspiTerrie E Moffitt
Feb 5, 2015·JAMA Psychiatry·Madeleine GoodkindAmit Etkin
May 6, 2015·Annual Review of Neuroscience·Marcus E Raichle

❮ Previous
Next ❯

Citations

Nov 6, 2018·Psychological Medicine·Tom RosenströmEivind Ystrom
Mar 26, 2019·Brain : a Journal of Neurology·Franco CaudaTommaso Costa
Sep 15, 2018·Cerebral Cortex·Maxwell L ElliottAhmad R Hariri
Nov 12, 2019·Cerebral Cortex·Andrew E ReinebergNaomi P Friedman
May 28, 2019·Nature Reviews. Neuroscience·Martijn P van den Heuvel, Olaf Sporns
Jul 1, 2020·The American Journal of Psychiatry·Adrienne L RomerAhmad R Hariri
Mar 8, 2020·Schizophrenia Bulletin·Debo DongDezhong Yao
May 7, 2020·Molecular Psychiatry·Maxime TaquetPaul J Harrison
May 7, 2020·Nature·Michael Marshall
Aug 7, 2019·Nature Human Behaviour·Siemon C de LangeMartijn P van den Heuvel
Aug 10, 2019·International Journal of Methods in Psychiatric Research·Katrina A S DavisMatthew Hotopf
Oct 20, 2020·Journal of Personality Disorders·Mohammad H AfzaliPatricia Conrod
Jan 13, 2021·World Psychiatry : Official Journal of the World Psychiatric Association (WPA)·Benjamin B LaheyDavid H Zald
Feb 25, 2020·Social Science & Medicine·Nandini KarunamuniDharshini Goonetilleke
Jun 3, 2020·Neuroscience and Biobehavioral Reviews·Ting LiChunliang Feng
Dec 4, 2020·European Psychiatry : the Journal of the Association of European Psychiatrists·Pei-Chi TuYa-Mei Bai
Feb 3, 2021·Molecular Psychiatry·Emma SprootenCorina U Greven
Mar 5, 2020·Biological Psychiatry : Cognitive Neuroscience and Neuroimaging·Xiaolong ZhangDanielle S Bassett
Mar 21, 2021·NeuroImage. Clinical·Shinsuke KoikeUNKNOWN Brain/MINDS Beyond Human Brain MRI Group
Mar 27, 2021·Development and Psychopathology·Peter FonagyPatrick Luyten
Mar 27, 2021·Journal of Autism and Developmental Disorders·S E Schulz, R A Stevenson
Mar 30, 2021·NeuroImage. Clinical·Lucy D Vanes, Raymond J Dolan
Nov 25, 2020·Biological Psychiatry : Cognitive Neuroscience and Neuroimaging·Nicole R KarcherDeanna M Barch
May 15, 2021·Psychological Medicine·Whitney R RingwaldAidan G C Wright
Jun 9, 2021·Psychological Medicine·Debo DongCheng Luo

❮ Previous
Next ❯

Related Concepts

Related Feeds

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.